Indonesia : Development of Academic Health System of Padjadjaran University in West Java (AIIB-001122)

Countries
  • Indonesia
Geographic location where the impacts of the investment may be experienced.
Specific Location
West Java
Whenever identified, the area within countries where the impacts of the investment may be experienced. Exact locations of projects may not be identified fully or at all in project documents. Please review updated project documents and community-led assessments.
Financial Institutions
  • Asian Infrastructure Investment Bank (AIIB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Proposed
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
B
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Borrower
Republic of Indonesia, Dian Lestari
A public entity (government or state-owned) provided with funds or financial support to manage and/or implement a project.
Sectors
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
Loan
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 53.44 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Loan Amount (USD)
$ 53.44 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Project Cost (USD)
$ 58.74 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Primary Source

Original disclosure @ AIIB website

Updated in EWS Nov 10, 2026

Disclosed by Bank Aug 4, 2026


Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

According to bank's website, the proposed project aims to strengthen the West Java Academic Health System through the development of RS UNPAD’s healthcare service delivery, medical education, and research capacity, along with the development of a center of excellence for tuberculosis. The Project Investment will be carried out with the below Project Components: 

Component A – Civil Works: A range of infrastructure investments will support the academic system development program of RS UNPAD. Key buildings under AIIB’s financing include an outpatient and medical education building, inpatient building, infectious disease and immunology research center specializing in Tuberculosis and an advanced therapy and diagnostics center of excellence. The structures form a part of the overall development plan, with other buildings to be developed at a later stage with other financing sources. 

Component B – Procurement of equipment: The proposed upgrade of RS UNPAD includes advanced medical and research equipment to help transform it into a tertiary-level referral center with integrated clinical, research, and education functions. The package covers major clinical specialties, advanced diagnostics and imaging, laboratory and infectious disease testing, surgical and interventional systems, research platforms for Tuberculosis and vaccine development, and hospital systems for inpatient care and operations. 

Component C – Human Capital Development: The government of Indonesia will finance the entire Component C, and it consists of multiple subcomponents. The service subcomponent strengthens academic and health services at the primary, referral, and specialized levels. It links teaching hospitals, primary care, laboratories, clinical trial centers, and partner hospitals to improve service quality and support innovation. 

Component D – Project Implementation Support: AIIB financing will support the engagement of procurement and technical consultants, including construction supervision and management consultants, medical and laboratory equipment consultants, and specialists such as a civil engineering expert, medical service management expert, and financial auditing consultant. It will also finance Project management support, including relevant consultants to strengthen operational governance, helping ensure an effective transition from construction to operations. 

Investment Description
Here you can find a list of individual development financial institutions that finance the project.

The total estimated project cost is USD58.74 million of which AIIB loan will fund up to USD53.44 million. 


Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.

Project Team Leader: Deni Fauzi 

Title: Senior Investment Officer 

Email: deni.fauzi@aiib.org 

ACCESS TO INFORMATION

You can submit an information request for project information at: https://www.aiib.org/en/contact/information-request/index.html

ACCOUNTABILITY MECHANISM OF AIIB

The AIIB has established the Accountability Mechanism for Project-Affected People (PPM). The PPM provides Òan opportunity for an independent and impartial review of submissions from Project-affected people who believe they have been or are likely to be adversely affected by AIIBÕs failure to implement the ESP in situations when their concerns cannot be addressed satisfactorily through Project level GRMs or AIIB Management processes.Ó Two or more project-affected people can file a complaint. Under the current AIIB policy, when the bank co-finances a project with another development bank, it may apply the other bank's standards. You can refer to the Project Summary Information document to find out which standards apply. You can learn more about the PPM and how to file a complaint at: https://www.aiib.org/en/about-aiib/who-we-are/project-affected-peoples-mechanism/how-we-assist-you/index.html

The complaint submission form can be accessed in Arabic, Bahasa Indonesia, Bengali, Chinese, English, Tagalog, Hindi, Nepali, Russian, Turkish, or Urdu. The submission form can be found at: https://www.aiib.org/en/about-aiib/who-we-are/project-affected-peoples-mechanism/submission/index.html

How it works

How it works